Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9028064rdf:typepubmed:Citationlld:pubmed
pubmed-article:9028064lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:9028064lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:9028064lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:9028064lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:9028064pubmed:issue2lld:pubmed
pubmed-article:9028064pubmed:dateCreated1997-2-28lld:pubmed
pubmed-article:9028064pubmed:abstractTextA total of 114 pT4 patients underwent pulmonary resection from January 1980 to December 1993 at our hospital. The overall five-year survival rate of the 114 cases was 17%. There was no significance between the five-year survival rate of squamous cell carcinoma and that of adenocarcinoma. Five-year survival rates of 17 patients with N0 disease, 29 patients with N1 disease, 51 patients with N2 disease, 1 patients with N3 disease, and 16 patients with NX disease were 40%, 21%, 21%, 0%, and 0%, respectively. Five-year survival rate of 89 cases with single factor of T4 was 24% and that of 25 cases with more than one factor was 4% (0.05 < P < 0.1). In the patients with only single factor of T4, five-year survival rates of 6 patients with left atrium invasion, 13 patients with major vessel invasion, 9 patients with trachea/carina invasion, and 18 patients with vertebral body, were 50%, 38%, 22%, and 0%, respectively. Furthermore, in 38 pT4 patients with involvement only to single adjacent structure, five-year survival rates were 47% in curative operation (n = 17) and 10% in non-curative operation (n = 21) (P < 0.05). We conclude that surgical treatment for T4 lung cancer should be performed to patients with single structure invasion which is expected to have a curative operation. N0 disease is more favorable than N1 or N2 disease.lld:pubmed
pubmed-article:9028064pubmed:languagejpnlld:pubmed
pubmed-article:9028064pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9028064pubmed:citationSubsetIMlld:pubmed
pubmed-article:9028064pubmed:statusMEDLINElld:pubmed
pubmed-article:9028064pubmed:monthFeblld:pubmed
pubmed-article:9028064pubmed:issn0021-5252lld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:TakahashiSSlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:SatoMMlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:SaitoYYlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:TakahashiHHlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:FujimuraSSlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:ChenYYlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:KandaAAlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:AikawaHHlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:EndoOOlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:UsudaKKlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:SakuradaAAlld:pubmed
pubmed-article:9028064pubmed:authorpubmed-author:SagawaMMlld:pubmed
pubmed-article:9028064pubmed:issnTypePrintlld:pubmed
pubmed-article:9028064pubmed:volume50lld:pubmed
pubmed-article:9028064pubmed:ownerNLMlld:pubmed
pubmed-article:9028064pubmed:authorsCompleteYlld:pubmed
pubmed-article:9028064pubmed:pagination95-100lld:pubmed
pubmed-article:9028064pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:meshHeadingpubmed-meshheading:9028064-...lld:pubmed
pubmed-article:9028064pubmed:year1997lld:pubmed
pubmed-article:9028064pubmed:articleTitle[The significance of surgical treatment for T4 lung cancer].lld:pubmed
pubmed-article:9028064pubmed:affiliationDepartment of Thoracic Surgery, Tohoku University, Sendai, Japan.lld:pubmed
pubmed-article:9028064pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9028064pubmed:publicationTypeEnglish Abstractlld:pubmed